Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3

Prostate

Volumn 38, Issue 3, 1999, Pages 228-236

  Liang, J Y ^a   Fontana, J A ^b   Rao, J N ^a   Ordonez, J V ^b   Dawson, M I ^c   Shroot, B ^d   Wilber, J F ^b   Feng, P ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c SRI INTERNATIONAL   (United States)

^d Galderma R and D   (France)

Author keywords

Apoptosis; CD437; Cell cycle; Growth inhibition; p21(waf1 cip1 sdi1); Retinoid

Indexed keywords

2 NAPHTHOIC ACID DERIVATIVE; 6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ANDROGEN; BROXURIDINE; DNA FRAGMENT; DRUG VEHICLE; MESSENGER RNA; PROTEIN P21; PROTEIN P53; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE S PHASE; CONTROLLED STUDY; GENE EXPRESSION; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; HUMANS; MALE; PROSTATIC NEOPLASMS; RETINOIDS; S PHASE; TUMOR CELLS, CULTURED;

EID: 0033557347     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990215)38:3<228::AID-PROS7>3.0.CO;2-T     Document Type: Article

References (43)

1. Pennisi E. Homing in on prostate cancer gene. Science 1996;22: 1301.
2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. Cancer J Clin 1996;46:5-27.
3. Denmeade SR, Lin XS, Isaacs JT. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostate 1996;28:251-265.
4. Zhuang S-H, Burnstein KL. Antiproliferative effect of 1a,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 1998;139:1197-1207.
5. Mordente JA, Konno S, Chen YP, Wu JM, Tazaki H, Mallouh C. The effects of brefeldin A (BFA) on cell cycle progression involving the modulation of the retinoblastoma protein (pRB) in PC-3 prostate cancer cells. J Urol 1998;159:275-279.
6. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980;605:33-91.
7. Slawin K, Kadmon D, Park SH, Scardino PT, Anzano M, Sporn MB, Thompson TC. Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras+myc-induced carcinomas in the mouse prostate reconstitution model system. Cancer Res 1993;53:4461-4465.
8. Pollard M, Luckert PH, Sporn MB. Prevention of primary prostate cancer in Lobund-Wistar rats by N-(4-hydroxyphenyl)retinamide. Cancer Res 1991;51:3610-3611.
9. Igawa M, Tanabe T, Chodak GW, Rukstalis DB. N-(4-hydroxyphenyl) retinamide induces cell cycle specific growth inhibition in PC-3 cells. Prostate 1994;24:299-305.
10. Dahiya R, Park HD, Cusick J, Vessella RL, Fournier G, Narayan P. Inhibition of tumorigenic potential and prostate-specific antigen expression in LNCaP human prostate cancer cell line by 13-cis-retinoic acid. Int J Cancer 1994;59:126-132.
11. Lu X-P, Fanjul A, Rideout D, Shroot B, Pfahl M. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type. (in press)
12. Chen JY, Penco S, Ostrowski J, Balaguer P, Pons M, Starrett JE, Reczek P, Chambon P, Gronemeyer H. RAR-specific agonist/ antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J 1995;14:1187-1197.
13. Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, Pfahl M. Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Mol Endocrinol 1993;7:1347-1356.
14. 1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 1995;11:493-504.
15. Schadendorf D, Kern MA, Artuc M, Pahl HL, Rosenbach T, Fichtner I, Nurnberg W, Stuting S, Stebut EV, Worm M, Makki A, Jurgovsky K, Kolde G, Henz BM. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo. J Cell Biol 1996;135:1889-1898.
16. Oridate N, Higuchi M, Suzuki S, Shroot B, Hong WK, Lotan R. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl) hydroxyphenyl]-2-naphtalene carboxylic acid (CD437). Int J Cancer 1997;70:484-487.
17. Charpentier B, Bernardon JM, Eustache J, Millois C, Martin B, Michel S, Shroot B. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. J Med Chem 1995;38:4993-5006.
18. Tonkinson JL, Marder P, Andis SL, Schultz RM, Gossett LS, Shih C, Mendelsohn LG. Cell cycle effects of antifolate antimetabolites: implications for cytotoxicity and cytostasis. Cancer Chemother Pharmacol 1997;39:521-531.
19. Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT, Davidson NE. Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 1994;54:5280-5283.
20. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
21. Rao JN, Debeljuk L, Bartke A, Gao YP, Wilber JF, Feng P. The detection of thyrotropin-releasing hormone (TRH) and TRH receptor gene expression in Siberian hamster testes. Peptides 1997; 18:1217-1222.
22. Sherr CJ. Cancer cell cycles. Science 1996;274:1672-1677.
23. Hartwell LH, Weinert TA. Checkpoints, controls that ensure the order of cell cycle events. Science 1989;246:629-634.
24. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-816.
25. Dulio V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ, Reed SI. p53-dependent inhibition of cyclindependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 1994;76:1013-1023.
26. Li WW, Han J, Hochhauser D, Bertino JR. Overexpression of p21waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Cancer Res 1997;57:2193-2199.
27. Hsieh J-K, Fredersdorf S, Kouzarides T, Martin K, Lu X. E2F-1-induced apoptosis requires DNA binding but not transactivation and is inhibited by retinoblastoma protein through direct interaction. Genes Dev 1997;11:1840-1852.
28. Krek W, Xu G, Livingston DM. Cyclin A-kinase regulation of E2F-1 DNA binding function underlines suppression of an S phase checkpoint. Cell 1995;83:1149-1158.
29. Waldman T, Lengauer C, Kinzler KW, Vogelstein B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996;381:713-716.
30. waf1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 1996;16:1335-1341.
31. 2-mediated cellular arrest and death. Cancer Res 1996;56:475-479.
32. waf1/cip1 expression prevents p53-mediated apoptotic cell death of human melanoma cells. Oncogene 1997;14:929-935.
33. waf1/cip1/sdi1 in cell death and DNA repair as studied using a tetracycline inducible system in p53-deficient cells. Oncogene 1997;14:1875-1882.
34. Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP. Irradiation induces Waf1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem 1995;270: 19181-19187.
35. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75: 817-825.
36. cip1/waf1 expression by cellular stress: p53-dependent and p53-independent mechanisms. Mol Cell Differ 1996;4:47-65.
37. Johnson M, Dimitrov D, Vojta PJ, Barrett JC, Noda A, Pereira-Smith OM, Smith JR. Evidence for a p53-independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol Carcinog 1994;11:59-64.
38. Michieli PM, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53 independent pathway. Cancer Res 1994;54:3391-3395.
39. Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, Jackman J, O'Connor PM, Anderson CW, Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 1995;270:29386-29391.
40. waf1/cip1 gene by retinoic acid receptor. J Biol Chem 1996;271:31723-31728.
41. waf1/cip1 expression in human breast carcinoma cells. Cancer Res 1996;56:5053-5062.
42. Hsu KA, Rish AK, Li X-S, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Fontana JA. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor independent pathway. Blood 1997;89:4470-4479.
43. Oridate N, Suzuki S, Higuchi M, Mitchell MF, Hong WK, Lotan R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl) retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst 1997;89:1191-1198.